A case of bullous pemphigoid and renal disease after dipeptidyl peptidase 4 inhibitor administration

CEN Case Rep. 2023 Dec 6. doi: 10.1007/s13730-023-00835-1. Online ahead of print.

Abstract

A 62-year-old man with type 2 diabetes was admitted because of a decrease in estimated glomerular filtration rate from 72 to 17.5 mL/min/1.73 m2 in 10 years and development of widespread bullous skin lesions. His hemoglobin A1c level had been maintained at 6.0-7.0% for 10 years with a dipeptidyl peptidase (DPP)-4 inhibitor. Skin biopsy showed typical bullous pemphigoid, and kidney biopsy showed tubulointerstitial nephritis with eosinophilic infiltration and glomerular endothelial cell proliferation. After discontinuing the DPP-4 inhibitor, skin lesions improved, and renal decline slowed. This case indicates that DPP-4 inhibitors can cause not only skin lesions but also renal disease.

Keywords: Bullous pemphigoid; Diabetic nephropathy; Dipeptidyl peptidase-4 inhibitor; Glomerular endothelial cell injury.